Abstract:This study explores novel vancomycin derivatives designed with disulfide groups to combat multidrug‐resistant bacteria. This research highlights enhanced binding affinities and improved pharmacokinetic properties of these derivatives, showcasing their potential against vancomycin‐resistant strains. Key findings include superior activity, improved absorption, distribution, and safety profiles, making these derivatives promising candidates for further development. The rise of multidrug‐resistant bacteria, such as Enterococcus faecium and Staphylococcus aureus, has compromised the efficacy of glycopeptide antibiotics like vancomycin. Consequently, novel strategies are urgently needed to combat vancomycin‐resistant strains. In this study, novel vancomycin derivatives with disulfide groups targeting the D‐alanyl‐D‐alanine for wild‐type, D‐alanyl‐D‐lactate, and D‐alanyl‐D‐serine regions for resistant strains were designed. Using ChemDraw Pro 12.0, the derivatives were created, and their binding affinities were assessed through molecular docking with AutoDock Vina. Molecular dynamics (MD) simulations were conducted with GROMACS 5.1.4, followed by MM/PBSA and quantum mechanical calculations. Pharmacokinetic properties were evaluated via ADMETlab 3.0. The derivatives showed enhanced binding energies across all target regions, irrespective of aromatic moieties or aliphatic groups. All three derivatives demonstrated higher logP values, improved gastrointestinal absorption, increased plasma protein binding percentages, better tissue distribution, and comparable half‐lives to vancomycin, along with favorable safety profiles. Among the vancomycin derivatives designed, derivative I emerged as a particularly promising candidate against vancomycin‐resistant strains, demonstrating superior binding energies and improved pharmacokinetic properties, thereby making it a strong candidate for further development.

Design and synthesis of new vancomycin derivatives.

Design and Synthesis of Pyrophosphate-Targeting Vancomycin Derivatives for Combating Vancomycin-Resistant Enterococci.

Design, Synthesis and Biological Activity of Novel Demethylvancomycin Dimers Against Vancomycin-Resistant Enterococcus Faecalis

Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus Aureus and Vancomycin-Resistant Enterococci.

Synthesis and Antibacterial Evaluation of Novel Vancomycin Derivatives Containing Quaternary Ammonium Moieties

Modification of Vancomycin Structure to Combat against Emerging Vancomycin Resistance

Enhancing the antibacterial efficacy of vancomycin analogues: targeting metallo-β-lactamases and cell wall biosynthesis

A Facile Method for Vancomycin C-terminus Functionalization and Derivatization Through Hydrazide

Optimization Of Globomycin Analogs As Novel Gram-Negative Antibiotics

Design, Synthesis, And Antibacterial Activity Of Demethylvancomycin Analogues Against Drug-Resistant Bacteria

Solid-phase Synthesis and Antibacterial Evaluations of N-demethylvancomycin Derivatives

Single Amine or Guanidine Modification on Norvancomycin and Vancomycin to Overcome Multidrug-Resistance through Augmented Lipid II Binding and Increased Membrane Activity

Design and Synthesis of Macrocycles Active Against Vancomycin-Resistant Enterococci (VRE): the Interplay Between D-Ala-d-lac Binding and Hydrophobic Effect

Potentiation of Vancomycin: Creating Cooperative Membrane Lysis through a “Derivatization-for-Sensitization” Approach

Identification of Synthetic Compounds Active Against Vre: the Role of the Lipidated Aminoglucose and the Structure of Glycopeptide Binding Pocket

Design, synthesis and antifungal activity of novel vanillin derivatives containing thiazole and acylhydrazone moieties.

Importance of the Structure of Vancomycin Binding Pocket in Designing Compounds Active Against Vancomycin-resistant Enterococci (VRE)

Vancomycin-Polyguanidino Dendrimer Conjugates Inhibit Growth of Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria and Eradicate Biofilm-Associated S. aureus

Design and Synthesis of Simple Macrocycles Active Against Vancomycin-Resistant Enterococci (VRE).

Combination of Vancomycin and Guanidinium-Functionalized Helical Polymers for Synergistic Antibacterial Activity and Biofilm Ablation

Tetrachlorovancomycin: Total Synthesis of a Designed Glycopeptide Antibiotic of Reduced Synthetic Complexity